Kary Eldred - 06 Feb 2026 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Reporting relationship: Director
Issuer ticker: GALT
Reported as of: 06 Feb 2026
Net transaction value: +$810
SEC form: 4
Accepted by SEC: 09 Feb 2026, 16:25:19 UTC
Prior SEC filing: 21 Jan 2026
Source filing: View source filing
Reporting owner signature: Jack W. Callicutt, by power of attorney

Key filing fact

Kary Eldred filed Form 4 for GALECTIN THERAPEUTICS INC (GALT) on 09 Feb 2026.

Key facts

This page summarizes Kary Eldred's Form 4 filing for GALECTIN THERAPEUTICS INC (GALT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 09 Feb 2026, 16:25.

Change

Previous filing in this sequence was filed on 21 Jan 2026.
Current net transaction value: +$810.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001543425 Primary reporting owner

ELDRED KARY

Relationship: Director
Address: C/O GALECTIN THERAPEUTICS INC., 4960 PEACHTREE INDUSTRIAL BLVD., STE 240, NORCROSS
Signature: Jack W. Callicutt, by power of attorney
Signature date: 09 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GALT transaction

Common Stock

Purchase

Transaction value: $810
Shares: +300
Change %: +0.46%
Price: $2.70
Shares after: 65,682
Date: 06 Feb 2026
Ownership: Direct

GALT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,425
Date: 06 Feb 2026
Ownership: as UTMA custodian for a minor child
Footnotes: F1

GALT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,000
Date: 06 Feb 2026
Ownership: held in trust
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purpose of Section 16 or for any other purpose.

Footnote F2

These shares are held in a special needs trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.